Top Markets
Coin of the day
AIM ImmunoTech Inc. AIM ImmunoTech Inc.

AIM ImmunoTech Inc.

AIM
Rankning i aktier #38740
AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida,... AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, naturally derived, multi-species alpha interferon prescribed for genital warts. Furthermore, Ampligen is currently undergoing investigation for its potential application in treating pancreatic, renal cell, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, and prostate cancers, as well as myalgic encephalomyelitis, Hepatitis B, HIV, COVID-19, and post-COVID conditions. The company, originally incorporated in 1966, was formerly known as Hemispherx Biopharma, Inc. until its name change in August 2019.
Aktiekurs
$0.2426
Marknadsvärde
$825.70K
Förändring (1 dag)
-6.08%
Förändring (1 år)
-89.98%
Land
US
Handel AIM ImmunoTech Inc. (AIM)

Kategori

P/S-tal för AIM ImmunoTech Inc. (AIM)
P/S-tal per 2026 TTM: 0
Enligt AIM ImmunoTech Inc. senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 0. I slutet av 2026 hade företaget ett P/S-tal på 0.
Historik för P/S-tal för AIM ImmunoTech Inc. från 2026 till 2026
P/S-tal vid årets slut
År P/S-tal Ändra
Inte tillräckligt med data för de angivna datumen.
P/S-tal för liknande företag eller konkurrenter
Företag P/S-tal Skillnad i P/S-tal Land
9.88 -
US
10.30 -
NL
- -
CH
- -
KR
4.98 -
BE